FDA Label for Eclipse Topical Analgesic FA

View Indications, Usage & Precautions

Eclipse Topical Analgesic FA Product Label

The following document was submitted to the FDA by the labeler of this product Sambria Pharmaceuticals, Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

​Active Ingredients



Benzocaine     20.0% w/w


​Purpose



External Analgesic


​Uses



For temporary relief of pain and itching due to minor skin irritation.


​Warnings



​For external use only

Avoid contact with eyes


Otc - Stop Use



​Stop use and ask doctor if

• Condition worsens, or if symptoms persist for more then 7 days or clear up and occur again within a few days.  Discontinue use.


Otc - Keep Out Of Reach Of Children



​Keep out of reach of children

• If product is swallowed, get medical help or contact a Poison Control Center right away.


​Directions



For adults and children two-years or older: Apply to affected area not more then 3 or 4 times daily.  Children under 2 years of age: consult a physician.


​Inactive Ingredients



Aqua (Deionized Water), Arnica Montana Flower Extract, C13-14 Isoparaffin, Caprylic/Capric Triglyceride, Cetearetj-25, Chondroitin Sulfate, Diethylhexyl Sodium Sulfosuccinate, Emu Oil, Ethoxydiglycol, Ethylhexylglycerin, Glucosamine Sulfate, Glycerin, Isopropyl Palmitate, Laureth-7, Melaleuca alternifolia (Tea Tree) Leaf Oil, Methylfulfonylmenthane (MSM), Phenoxyethanol, Polyacrylamide, Polysorbate-20, Safflower Oil, Stearic Acid, Triethanolamine


​Other Information



Protect this product from excessive heat or direct sun.


​Questions Or Comments?



FDA Registered: NDC No. 54723-668-03

800-759-6876


Package Label.Principal Display Panel




* Please review the disclaimer below.